Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Jaguar Health (JAGX) over the last 6 years, with Q3 2025 value amounting to $170000.0.

  • Jaguar Health's Current Deferred Revenue changed 0.0% to $170000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $170000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $170000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Jaguar Health reported Current Deferred Revenue of $170000.0 as of Q3 2025, which was down 0.0% from $170000.0 recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Current Deferred Revenue ranged from a high of $170000.0 in Q1 2024 and a low of $170000.0 during Q1 2024